VIMY Vimy Pharmaceuticals Inc.

1.889USD2.700 CAD · TSXVMkt Cap: —P/E: —

Vimy Pharmaceuticals Inc. manufactures complex medicines intended to treat chronic diseases and improve patient access to care. The company manufactures complex medicines and therapeutic products, enabling healthcare pro…

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price1.889 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
1.8890% of range2.099
52W High2.099 USD
52W Low1.889 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA—
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg12.08%
Avg Vol (30d)98.30K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—

About Vimy Pharmaceuticals (CVE: VIMY)

›

Vimy Pharmaceuticals (CVE: VIMY) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 2.700 CAD on 17 November 2026. Its 52-week range is 2.700 CAD to 3.000 CAD, and it trades at the bottom of that range.

Vimy Pharmaceuticals reports an operating margin of 0.0%.